L-Carnitine for Heart Health Support
L-carnitine improved outcomes after myocardial infarction in older pooled analyses, but concerns about TMAO production complicate the picture.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- 2 g/day L-carnitine, or 1-3 g/day propionyl-L-carnitine for peripheral arterial disease, taken with meals in divided doses
- Expected timeframe
- 8-12 weeks
Protocol
- form
- L-carnitine for cardiac endpoints; propionyl-L-carnitine has been studied specifically in intermittent claudication and peripheral arterial disease. Avoid D-carnitine and DL-carnitine
- duration
- 12 weeks minimum for symptomatic endpoints
- co factor
- Take with meals. Evidence is genuinely mixed and points in both directions, which is unusual. On the positive side, a meta-analysis of trials in acute myocardial infarction reported reduced all-cause mortality, ventricular arrhythmias and angina with L-carnitine, and propionyl-L-carnitine has shown improved walking distance in peripheral arterial disease. Carnitine deficiency also causes a genuine, treatable cardiomyopathy. On the negative side, carnitine is metabolised by gut bacteria to TMAO, which is associated in prospective cohorts with increased cardiovascular events - so the same molecule appears beneficial in trials and adverse via a metabolite. This tension is unresolved, and no large modern outcome trial has settled it.
- titration
- Up to 2-3 g/day in divided doses; do not exceed 4 g/day
- starting dose
- 1 g twice daily with meals
Evidence
What the studies say
No studies are yet linked to both L-Carnitine and Heart Health Support.
Safety
Caveats
Do not use carnitine in place of proven cardiovascular treatment - statins, antiplatelets, blood pressure control and cardiac rehabilitation have outcome data that no supplement matches, and prescribed medication should not be stopped or reduced. Chest pain on exertion, breathlessness at rest, ankle swelling or palpitations need medical assessment; chest pain with sweating, nausea or arm or jaw pain is an emergency. Safety ceiling: above 3 g/day expect nausea, vomiting, cramps, diarrhoea and fishy body odour; do not exceed 4 g/day. The TMAO concern is most pertinent precisely in this population - carnitine supplementation raises TMAO, which prospective studies link to cardiovascular events, so discuss long-term use with your cardiologist. Carnitine may potentiate warfarin - monitor INR. Avoid in seizure disorders, where increased seizure frequency has been reported, and in hypothyroidism. Use with caution in kidney disease, including dialysis patients, where prescribed carnitine is sometimes used but under supervision. Insufficient safety data in pregnancy and breastfeeding - avoid in both.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.